Future Science Group
Browse
Immunotherapy_Submission_Supplementary_Table_22Dec22.docx (55.27 kB)

Real-world maintenance therapy and survival outcomes for pembrolizumab plus pemetrexed and platinum for non-small-cell lung cancer in USA. Supplementary table

Download (55.27 kB)
dataset
posted on 2023-02-15, 08:34 authored by Jong Seok Kim, Yajun Emily Zhu, Catherine Elizabeth Muehlenbein, Yimei Han, KayOnda Bayo, Himani Aggarwal

Supplementary table

History